US › Healthcare

Natera Inc (NTRA)

US · Healthcare · Diagnostics & Research

$275.19+1.79%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$696.6M
Revenue YoY
+38.8%
Net profit
$-85.1M
Profit YoY
-27.1%
EPS
$-0.60
EPS estimate
$-0.55
Net margin
-12.2%

EPS came in at -0.60 against a street estimate of -0.55 — a miss of 9.1%.

Key statistics

Market cap
$38.72B
Forward P/E
0.0
P/B
21.62
Book value
$12.43
EPS (TTM)
$-1.65
52-week high
$288.04
52-week low
$135.75
50-day MA
$244.72
200-day MA
$220.57
Beta
1.51

Analyst view

Analysts rate Natera Inc a buy (20 buy, 0 hold, 1 sell out of 21) with an average price target of $282.86.

Shareholding

Insiders
2.98%
Institutions
95.99%

Largest institutional holders

FundStake
JPMorgan Chase & Co9.38%
Vanguard Group Inc8.62%
T. Rowe Price Associates, Inc.8.53%
BlackRock Inc7.48%
Vanguard Capital Management, LLC4.21%
Vanguard Portfolio Management, LLC3.95%
Wellington Management Company LLP3.34%
State Street Corp2.39%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Natera Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.